Vol. 7 (09) pp. 1031-1036 DOI: 10.21474/IJAR01/9753

CURATIVE CHEMOTHERAPY FOR INTUBATED PATIENTS. SHOULD WE.

, , , , and
33 Downloads 218 Views
Crossref

Download Full Paper (PDF)

Abstract

Introduction: The management of patients with cancer, presenting an immediate life-threatening risk is a complex and controversial subject. The admission of those patients to the care unit poses a real dilemma, we are torn between the desire to go to the limits of technical possibilities especialy for young patients. Materials and methods: We report 4 cases of patients, admitted in intensive care unit for respiratory distress causes by a tumor. These patients were intubation because of hypoxemia, and then received curative chemotherapy in the intensive care unit. Discussion: A few years ago, admission to intensive care unit for onco-hematology patients was unthinkable. It still is nowadays, we are torn between the desires to go to the limits of technical possibilities especialy for young patients. A study of ICU admissions for any type of lung carcinoma (80% of Non-Small Cell Bronchial Cancers) shows that of the 22,538 patients in stages III-IV, 16360 leave the hospital and 4,889 survive at 6 months. Only 11% of mechanically ventilated patients leave the hospital. In our study, one of the four patients treated with chemotherapy responded well, a ratio of 25%. Conclusion: Admission decisions of patient with neoplasia to the ICU should be made on a case-by-case basis, somewhere between the two ends of the decision-making spectrum, based on the clinical evaluation and after discussions with the oncologist andpatient

Keywords

Article Analytics

References

  1. Garin?; Admission in care unit of patients with neoplasia bad prognosis, Rev Med Switzerland 2005; volume 1.?30808
  2. Berghmans T, Paesmans M, Sculier JP. Is a specific oncologi-cal scoring system better at predicting the prognosis of cancer patients admitted for an acute medical complication in an intensive care unit than general gravity scores? Support CareCancer 2004;12:234?9.
  3. Sculier JP, Paesmans M, Markiewicz E, et al. Scoring systemsin cancer patients admitted for an acute complication in amedical intensive care unit. Crit Care Med 2000;28:2786?92.
  4. Azoulay E, Moreau D, Alberti C, et al. Predictors of short-term mortality in critically ill patients with solid malignancies.Intensive Care Med 2000;26:1817?23.
  5. Vallot F, Paesmans M, Berghmans T, et al. Leucopenia is anindependent predictor in cancer patients requiring invasivemechanical ventilation: a prognostic factor analysis in a seriesof 168 patients. Support Care Cancer 2003;11:236?41.
  6. Thi?ry.G et coll., Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study, Journal of clinical oncology 2005, july, , volume 23.
  7. Nicole Pitelo et coll., Approches for administering chemotherapy in intensive care unit, Current drug safety 2010,5, 22-32.
  8. Chabner BA, Amrein PC, Druker BJ, et al. Chemotherapy of Neoplastic Diseases. In: Goodman and Gilman?s, Eds. ThePharmacological Basis of Therapeutics. 11th ed. New York NY: McGraw-Hill Companies, Inc 2006; pp. 1315-1403.
  9. Devita, VT, Hellman S, Rosenberg SA, Eds. Pharmacology of Cancer Chemotherapy. In: Cancer Principles and Practice of Oncology 7th ed. New York, NY: Lippincott Williams and Wilkins 2005; pp. 307-422.
  10. Park SY, Lim SY, Um SW, et al. Outcome and predictors ofmortality in patients requiring invasive mechanical ventilationdue to acute respiratory failure while undergoing ambula-tory chemotherapy for solid cancers. Support Care Cancer2013;21:1647?53.
  11. Jennens RR, Rosenthal MA, Mitchell P, et al. Outcome of patients admitted to the intensive care unit with newly diag-nosed small cell lung cancer. Lung Cancer 2002;38:291?6.
  12. Toffart AC, Dhalluin X, Girard N, Chouaid C, Audigier-ValetteC, Duruisseaux M, et al. Patients with advanced lung cancerharboring oncogenic mutations should be admitted to intensivecare units. Intensive Care Med 2015;41:164?5.
  13. M Dewolf et Al ; Efficacy of erlotinib in intensive care for patients with non-small cell lung cancer with EGFR mutation; Clinical Pneumology Journal (2017) 73, 135?139
  14. Bosch-Barrera J, Sais E, Lorencio C, Porta R, Izquierdo A,Men?ndez JA, et al. Successful empirical erlotinib treatment ofa mechanically ventilated patient newly diagnosed with metas-tatic lung adenocarcinoma. Lung Cancer 2014;86:102?4.
  15. Guillaume Thi?ry, al ;?Outcome of Cancer Patients Considered for Intensive Care?Unit Admission: A Hospital-Wide Prospective Study ;JOURNAL OF CLINICAL ONCOLOGYVOLUME 23 ?NUMBER 19 ?JULY 1 2005.

How to Cite This Article

Yassine Smiti, Ssouni oussama , Mouden Achraf , Abdelilah Ghannam, Brahim El Ahmadi and Zakaria Belkhadir. (2019); CURATIVE CHEMOTHERAPY FOR INTUBATED PATIENTS. SHOULD WE., Int. J. of Adv. Res., 7 (09), 1031-1036, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/9753

Corresponding Author

yassine smiti

Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.